EX-32.1 4 nrxp-20210630xex32d1.htm EX-32.1

Exhibit 32.1

​

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

In connection with the filing of the Quarterly Report on Form 10-Q for the three months ended June 30, 2021 (the “Report”) by NRx Pharmaceuticals, Inc. (the “Registrant”), I, Johnathan Javitt as Chief Executive Officer of the Registrant hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

​

| 1. | the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

​

| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

​

Date: August 16, 2021 | /s/ Jonathan Javitt
​ | Johnathan Javitt
​ | Chief Executive Officer (Principal Executive Officer)

​

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request